RedHill Biopharma (RDHL) Interest Coverage Ratio (2012 - 2023)

RedHill Biopharma (RDHL) has 12 years of Interest Coverage Ratio data on file, last reported at 27.91 in Q2 2023.

• Interest Coverage Ratio for Q2 2023 came in at 27.91, up 1184.06% year-over-year; the trailing twelve-month figure through Jun 2023 was 1.32 (up 78.89% YoY), and the FY2025 annual result was 5.45, down 27.37% from the prior year.
• Interest Coverage Ratio improved to 27.91 in Q2 2023 per RDHL's latest filing, from 69.07 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 167.3 in Q2 2019 and troughed at 69.07 in Q1 2023.
• A 5-year average of 15.0 and a median of 4.3 in 2020 frame the typical range for Interest Coverage Ratio.
• The sharpest annual moves came in 2019 and 2023: Interest Coverage Ratio surged 2905.64% in 2019, then plunged 1719.57% in 2023.
• A 5-year view of Interest Coverage Ratio shows it stood at 62.91 in 2019, then slumped by 93.12% to 4.33 in 2020, then slumped by 987.5% to 38.41 in 2021, then rose by 20.52% to 30.53 in 2022, then soared by 191.42% to 27.91 in 2023.
• Business Quant data shows RDHL's Interest Coverage Ratio at 27.91 in Q2 2023, 69.07 in Q1 2023, and 30.53 in Q4 2022.